Being an involved party of an auto accident is an overwhelming and frustrating life situation that happens to us when we least expect it to. According to data from 2009, about 100 people were injured …Read More
GranuFlo and NaturaLyte Lawsuits
GranuFlo and NaturaLyte are two chemical products that are commonly used in dialysis treatments across the United States. Recently, these products have been linked to cardiopulmonary arrest and sudden cardiac death. Fresenium Medical Care (FMC), the company that makes GranuFlo and NaturaLyte, knew about the risks associated with their products, but they failed to notify healthcare professionals and patients.
If GranuFlo and NaturaLyte were used during your dialysis treatment and you experienced an adverse side effect, you may be eligible to file a lawsuit. Contact a defective product attorney to learn about the legal rights afforded to GranuFlo and NaturaLyte patients.
GranuFlo and NaturaLyte Side Effects
Dialysis is a medical treatment that removes waste from the blood. GranuFlo and NaturaLyte are dry acid products that are used during the process. Sadly, many dialysis patients have reported serious GranuFlo and NaturaLyte side effects. Some common side effects that have been linked to GranuFlo and NaturaLyte include:
- Low blood pressure
- Heart attack
- Cardiac arrhythmia
- Cardiopulmonary arrest
- Sudden cardiac death
If you have experienced any of the side effects listed above, you may be eligible for legal and financial recourse.
To schedule a free case evaluation with a GranuFlo and NaturaLyte lawyer, fill out the contact form on the right.
Fresenium Medical Care Knew about Risks
On March 29, 2012, the Food and Drug Administration (FDA) issued a Class I recall for GranuFlo and NaturaLyte. A Class I recall is the most serious type of recall and it involves situations where there is a reasonable probability that the use of products will cause serious adverse health consequences or death.
FMC conducted a study that evaluated the risk factors of dialysis patients who suffered cardiopulmonary arrest in FMC facilities to other dialysis patients in the same facilities in 2010.
The results from the study showed that 941 patients at more than 600 facilities had suffered cardiopulmonary arrests that resulted in death.
Researchers found that these patients had six times the risk for cardiac arrest if they had an elevated pre-dialysis bicarbonate level.
FMC was aware of the risks associated with their dialysis patients that contained sodium diacetate. The company sent out an internal memo to FMCs doctors and dialysis facilities that notified them about the risks. However, FMC failed to warn the public about the risk for cardiac arrests. They only notified the public after the internal memo was leaked to the FDA.
Contact Our GranuFlo Injury Lawyers Today
Annually, 400,000 Americans receive dialysis treatments for kidney failure. GranuFlo and NaturaLyte are used in approximately in a third of dialysis treatments in the United Sates. Patients that are given these dry acid products during treatment are at an increased risk for serious side effects, including death.
If you or a family member was given GranuFlo and NaturaLyte during dialysis and suffered a cardiac arrest, you may be entitled to compensation for your losses. Contact the Tulsa personal injury lawyers at The Edwards Law Firm today to begin exploring your legal options. After your case review, an attorney will advise you on the best course of action to pursue.
The Edwards Law Firm is dedicated to helping injured individuals receive the justice that they deserve.